These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17886338)

  • 101. Altered innate immunity in chronic hepatitis C infection: cause or effect?
    Szabo G; Chang S; Dolganiuc A
    Hepatology; 2007 Oct; 46(4):1279-90. PubMed ID: 17886338
    [No Abstract]   [Full Text] [Related]  

  • 102. Hepatitis C virus (HCV) employs multiple strategies to subvert the host innate antiviral response.
    Bode JG; Brenndörfer ED; Häussinger D
    Biol Chem; 2008 Oct; 389(10):1283-98. PubMed ID: 18713016
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Hepatitis C virus (HCV): a review of immunological aspects.
    Irshad M; Khushboo I; Singh S; Singh S
    Int Rev Immunol; 2008; 27(6):497-517. PubMed ID: 19065353
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Immune responses in hepatitis C virus infection and mechanisms of hepatitis C virus persistence.
    Hiroishi K; Ito T; Imawari M
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1473-82. PubMed ID: 18761560
    [TBL] [Abstract][Full Text] [Related]  

  • 105. [Chronic hepatitis C: virologic and immunologic aspects].
    Moriya K; Koike K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):405-7. PubMed ID: 15359831
    [No Abstract]   [Full Text] [Related]  

  • 106. [Involvement of dendritic cell dysfunction in the persistence of hepatitis C virus infection].
    Kanto T; Hayashi N
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):170-4. PubMed ID: 15359787
    [No Abstract]   [Full Text] [Related]  

  • 107. Immunology of hepatitis C virus infections.
    Spaan M; Janssen HL; Boonstra A
    Best Pract Res Clin Gastroenterol; 2012 Aug; 26(4):391-400. PubMed ID: 23199499
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Immunology of hepatitis B and hepatitis C virus infections.
    Boonstra A; Woltman AM; Janssen HL
    Best Pract Res Clin Gastroenterol; 2008; 22(6):1049-61. PubMed ID: 19187866
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Natural killer cells in innate immunity and cancer.
    Becknell B; Caligiuri MA
    J Immunother; 2008 Oct; 31(8):685-92. PubMed ID: 18779751
    [No Abstract]   [Full Text] [Related]  

  • 110. [Activity of cytokines in chronic HCV-infected patients].
    Lapiński TW; Dabrowska MM
    Przegl Epidemiol; 2007; 61(4):747-54. PubMed ID: 18572507
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Natural killer cells: detectors of stress.
    Luci C; Tomasello E
    Int J Biochem Cell Biol; 2008; 40(11):2335-40. PubMed ID: 18595768
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Dendritic and natural killer cells cooperate in the control/switch of innate immunity.
    Zitvogel L
    J Exp Med; 2002 Feb; 195(3):F9-14. PubMed ID: 11828015
    [No Abstract]   [Full Text] [Related]  

  • 113. Co-ordinating innate and adaptive immunity to viral infection: mobility is the key.
    Christensen JE; Thomsen AR
    APMIS; 2009 May; 117(5-6):338-55. PubMed ID: 19400861
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Chronic hepatitis C in the advanced adult and elderly subjects.
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Petraccaro M
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):145-57. PubMed ID: 19305374
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Cancer Immunotherapy by coordinated stimulation of innate lymphocytes (NK and NKT cells).
    Fujii S
    Rinsho Ketsueki; 2009 May; 50(5):364-74. PubMed ID: 19483396
    [No Abstract]   [Full Text] [Related]  

  • 116. Mistaken notions about natural killer cells.
    Yokoyama WM
    Nat Immunol; 2008 May; 9(5):481-5. PubMed ID: 18425104
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Killers and beyond: NK-cell-mediated control of immune responses.
    Andoniou CE; Coudert JD; Degli-Esposti MA
    Eur J Immunol; 2008 Nov; 38(11):2938-42. PubMed ID: 18979519
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Experimental models for hepatitis C viral infection.
    Boonstra A; van der Laan LJ; Vanwolleghem T; Janssen HL
    Hepatology; 2009 Nov; 50(5):1646-55. PubMed ID: 19670425
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Killer dendritic cells and their potential role in immunotherapy.
    Ullrich E; Chaput N; Zitvogel L
    Horm Metab Res; 2008 Feb; 40(2):75-81. PubMed ID: 18283624
    [TBL] [Abstract][Full Text] [Related]  

  • 120. [Molecular physiopathology of viral hepatitis].
    Hayashi N; Kanto T; Hosui A; Sugimoto Y; Okawa K; Takehara T; Sasaki Y
    Nihon Naika Gakkai Zasshi; 2002 Sep; 91 Suppl():89-93. PubMed ID: 12577933
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.